SFX by Ex Libris Inc.

Title:	X-ray absorption spectroscopy of soybean lipoxygenase-1. Influence of lipid hydroperoxide activation and lyophilization on the structure of the non-heme iron active site
Source:	European Journal of Biochemistry [0014-2956] HEIJDT, Lambertus yr:1992

Basic

Full text

Full text available via Wiley Online Library Free Backfiles

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Shearer, J. "Synthetic Models for the Cysteinate-Ligated Non-Heme Iron Enzyme Superoxide Reductase: Observation and Structural Characterization by XAS of an FeIII-OOH Intermediate." Journal of the American Chemical Society 124.39 (2002): 11709-11717.
description	2.	Van Der Heijdt, Lambertus M. "Changes in the iron coordination sphere of Fe(II) lipoxygenase-1 from soybeans upon binding of linoleate or oleate." European journal of biochemistry 231.1 (1995): 186-191.
description	3.	FEIG, Andrew L. "REACTIONS OF NONHEME IRON(II) CENTERS WITH DIOXYGEN IN BIOLOGY AND CHEMISTRY." Chemical reviews 94.3 (1994): 759-805.
description	4.	Jamieson, E R R. "Structure, Recognition, and Processing of Cisplatin-DNA Adducts." Chemical reviews 99.9 (1999): 2467-98.
description	5.	Carroll, M. "Active-Site Models for the Nickel-Iron Hydrogenases: Effects of Ligands on Reactivity and Catalytic Properties." Inorganic chemistry 50.19: 9554-9563.
description	6.	George, Graham C. "Direct observation of bis-sulfur ligation to the heme of bacterioferritin." Journal of the American Chemical Society 115.17 (1993): 7716-7718.
description	7.	Ronde, J.-U. U. "Structural insights into nonheme alkylperoxoiron(III) and oxoiron(IV) intermediates by X-ray absorption spectroscopy." Journal of the American Chemical Society 126.51 (2004): 16750-16761.
description	8.	Hikichi, Shiro o. "Structural characterization and oxidation activity of a nickel(II) alkylperoxo complex." Angewandte Chemie (International ed.) 48.1 (2009): 188-4153.
description	9.	Wasinger, Erik C. "L-edge X-ray absorption spectroscopy of non-heme iron sites: Experimental determination of differential orbital covalency." Journal of the American Chemical Society 125.42 (2003): 12894-12906.
description	10.	sherman, S. "structural aspects of platinum anticancer drug interaction with dna." Chemical reviews 87.5 (1987): 1153-1181.
description	11.	Hermes, S. "A time-resolved iron-specific X-ray absorption experiment yields no evidence for an Fe2+ -> Fe3+ transition during Q(A)(-) -> Q(B) electron transfer in the photosynthetic reaction center." Biochemistry 45.2 (2006): 353-359.
description	12.	Dey, A. "Sulfur K-Edge XAS and DFT Calculations on Nitrile Hydratase: Geometric and Electronic Structure of the Non-heme Iron Active Site." Journal of the American Chemical Society 128.2 (2006): 533-541.
description	13.	Rosenzweig A C, Amy C. C. "Crystal structure of a bacterial non-haem iron hydroxylase that catalyses the biological oxidation of methane." Nature 366.6455 (1993): 537-543.
description	14.	Costas, M. "Dioxygen activation at mononuclear nonheme iron active sites: Enzymes, models, and intermediates." Chemical reviews 104.2 (2004): 939-986.
description	15.	Merkx, M. "Dioxygen activation and methane hydroxylation by soluble methane monooxygenase: a tale of two irons and three proteins." Angewandte Chemie 40.15 (2001): 2782-2807.
description	16.	Nicolet, Y. "Crystallographic and FTIR spectroscopic evidence of changes in Fe coordination upon reduction of the active site of the Fe-only hydrogenase from Desulfovibrio desulfuricans." Journal of the American Chemical Society 123.8 (2001): 1596-601.
description	17.	Pil, Pieter M. "Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin." Science 256.5054 (1992): 234-237.
description	18.	TAKAHARA, P M M. "CRYSTAL-STRUCTURE OF DOUBLE-STRANDED DNA CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN." Nature 377.6550 (1995): 649-652.
description	19.	Jung, Y. "Direct cellular responses to platinum-induced DNA damage." Chemical reviews 107.5 (2007): 1387-1407.
description	20.	Sherman, Suzanne E. "X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2{d(pGpG)}]." Science 230.4724 (1985): 412-417.